Moxifloxacin
Moxifloxacin comes in 15 pill versions in our database, in 1 strength, from 14 manufacturers. Check the imprint to tell them apart.
Moxifloxacin pill images
400 mg 15 pills
-
E 18
Moxifloxacin Hydrochloride 400 mg
Red, capsule, 17 mm
Used for bronchitis and sinus infections
- BAYER M400 Moxifloxacin Hydrochloride 400 mg Red, oval, 17 mm Used for bronchitis and sinus infections
- n 034 Moxifloxacin Hydrochloride 400 mg Pink, capsule, 17 mm Used for bronchitis and sinus infections
- 112 Moxifloxacin 400 mg Orange, capsule, 19 mm Used for bronchitis and sinus infections
- 103 J Moxifloxacin 400 mg Pink, capsule, 18 mm Used for bronchitis and sinus infections
- S9 Moxifloxacin Hydrochloride 400 mg White, capsule, 19 mm Used for bronchitis and sinus infections
- T75 Moxifloxacin 400 mg Pink, capsule, 17 mm Used for bronchitis and sinus infections
- CE 312 Moxifloxacin 400 mg Pink, capsule, 17 mm Used for bronchitis and sinus infections
- 93 7387 Moxifloxacin Hydrochloride 400 mg Pink, oval Used for bronchitis and sinus infections
- E 18 Moxifloxacin Hydrochloride 400 mg Red, capsule Used for bronchitis and sinus infections
- Moxi 400 Moxifloxacin Hydrochloride 400 mg Red, capsule Used for bronchitis and sinus infections
- E 18 Moxifloxacin Hydrochloride 400 mg Red, capsule Used for bronchitis and sinus infections
- E 18 Moxifloxacin Hydrochloride 400 mg Red, capsule Used for bronchitis and sinus infections
- No picture yet DIN 02383381 Moxifloxacin Hydrochloride 400 mg Sandoz Moxifloxacin, Tablet, sold in Canada Used for bronchitis and sinus infections
- No picture yet DIN 02472791 Moxifloxacin Hydrochloride 400 mg M-Moxifloxacin, Tablet, sold in Canada Used for bronchitis and sinus infections
What is Moxifloxacin used for?
Moxifloxacin is used for bronchitis, sinus infections, urinary tract infections (UTIs) and pneumonia.
- Medicine type
- Antibiotic (fluoroquinolone)
Official uses from the US prescribing label
Community Acquired Pneumonia
Moxifloxacin tablets are indicated in adult patients for the treatment of Community Acquired Pneumonia caused by susceptible isolates of Streptococcus pneumoniae(including multi-drug resistant Streptococcus pneumoniae[MDRSP]), Haemophilus influenzae, Moraxella catarrhalis,methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae,or Chlamydophila pneumoniae.
MDRSP isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [MIC] ≥ 2 mcg/mL), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole.
Uncomplicated Skin and Skin Structure Infections
Moxifloxacin tablets are indicated in adult patients for the treatment of Uncomplicated Skin and Skin Structure Infections caused by susceptible isolates of methicillin-susceptible Staphylococcus aureusor Streptococcus pyogenes.
Complicated Skin and Skin Structure Infections
Moxifloxacin tablets are indicated in adult patients for the treatment of Complicated Skin and Skin Structure Infections caused by susceptible isolates of methicillin-susceptible Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae,or Enterobacter cloacae.
Complicated Intra-Abdominal Infections
Moxifloxacin tablets are indicated in adult patients for the treatment of Complicated Intra-Abdominal Infections (cIAI) including polymicrobial infections such as abscess caused by susceptible isolates of Escherichia coli, Bacteroides fragilis, Streptococcus anginosus, Streptococcus constellatus, Enterococcus faecalis, Proteus mirabilis, Clostridium perfringens, Bacteroides thetaiotaomicron,or Peptostreptococcusspecies.
Plague
Moxifloxacin tablets are indicated in adult patients for the treatment of plague, including pneumonic and septicemic plague, due to susceptible isolates of Yersinia pestisand prophylaxis of plague in adult patients. Efficacy studies of moxifloxacin could not be conducted in humans with plague for feasibility reasons. Therefore, this indication is based on an efficacy study conducted in animals only.
Acute Bacterial Sinusitis
Moxifloxacin tablets are indicated in adult patients for the treatment of acute bacterial sinusitis (ABS) caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.
Because fluoroquinolones, including moxifloxacin tablets, have been associated with serious adverse reactions and for some patients ABS is self-limiting, reserve moxifloxacin tablets for treatment of ABS in patients who have no alternative treatment options.
Acute Bacterial Exacerbation of Chronic Bronchitis
Moxifloxacin tablets are indicated in adult patients for the treatment of Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB) caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae,methicillin-susceptible Staphylococcus aureus,or Moraxella catarrhalis.
Because fluoroquinolones, including moxifloxacin tablets, have been associated with serious adverse reactions and for some patients ABECB is self-limiting, reserve moxifloxacin tablets for treatment of ABECB in patients who have no alternative treatment options.
Usage
To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin tablets and other antibacterial drugs, moxifloxacin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
From the FDA-approved label on DailyMed (published Sep 14, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.